These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis. Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680 [TBL] [Abstract][Full Text] [Related]
5. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation. Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Wang D; Li SP; Fu JS; Bai L; Guo L Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767 [TBL] [Abstract][Full Text] [Related]
8. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse. Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of allogenic bone marrow mesenchymal stem cell transplantation on EAE mouse]. Liu P; Xuan X; Zhu J; Guan S; Du Y; Li Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):798-801. PubMed ID: 23948402 [TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
11. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766 [TBL] [Abstract][Full Text] [Related]
12. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288 [TBL] [Abstract][Full Text] [Related]
13. B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack. Kok LF; Marsh-Wakefield F; Marshall JE; Gillis C; Halliday GM; Byrne SN J Autoimmun; 2016 Sep; 73():10-23. PubMed ID: 27289166 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice. Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142 [TBL] [Abstract][Full Text] [Related]
15. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198 [TBL] [Abstract][Full Text] [Related]
16. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms. Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Kassis I; Petrou P; Halimi M; Karussis D Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102 [TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383 [TBL] [Abstract][Full Text] [Related]
19. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691 [TBL] [Abstract][Full Text] [Related]
20. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]